.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Covington
Colorcon
Baxter
Chubb
US Army
Medtronic
Moodys
Farmers Insurance

Generated: September 25, 2017

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-nine approved drugs.



Summary for Applicant: Actavis Mid Atlantic

Patents:0
Tradenames:57
Ingredients:47
NDAs:69
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic
CICLOPIROX
ciclopirox
SHAMPOO;TOPICAL090490-001Nov 24, 2009ATRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
ACYCLOVIR
acyclovir
SUSPENSION;ORAL074738-001Apr 28, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
NYSTATIN
nystatin
OINTMENT;TOPICAL062840-001Nov 13, 1987ATRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
CREAM;TOPICAL070885-001Feb 3, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
HYDROCORTISONE
hydrocortisone
CREAM;TOPICAL089682-001Mar 10, 1988ATRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
IBUPROFEN
ibuprofen
SUSPENSION;ORAL074916-001Apr 30, 1999OTCNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
codeine phosphate; promethazine hydrochloride
SYRUP;ORAL088763-001Oct 31, 1984AARXNoYes► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
BETAMETHASONE DIPROPIONATE
betamethasone dipropionate
OINTMENT, AUGMENTED;TOPICAL074304-001Aug 31, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
VALNAC
betamethasone valerate
CREAM;TOPICAL070050-001Oct 10, 1984ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
METOCLOPRAMIDE HYDROCHLORIDE
metoclopramide hydrochloride
SOLUTION;ORAL071340-001Aug 18, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Chubb
QuintilesIMS
Covington
Colorcon
UBS
AstraZeneca
Dow
Novartis
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot